Stayble Therapeutics AB (publ) (FRA:4K4)

Market Cap	1.22M -60.6%
Revenue (ttm)	-1.55K
Net Income	-979.33K
EPS	n/a
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	0.0230
Previous Close	0.0230
Day's Range	0.0230 - 0.0230
52-Week Range	0.0024 - 0.0489
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 27, 2026

About Stayble Therapeutics AB

Stayble Therapeutics AB (publ) a clinical pharmaceutical company, developing an injection-based treatments for disc herniation. It develops STA363, an injection into the disc that targets chronic low back and leg pain. The company was incorporated in 2015 and is based in Gothenburg, Sweden.

• Industry: Pharmaceutical Preparations
• Founded: 2015
• Employees: 2
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 4K4

Financial Performance

Financial numbers in SEK

Data Sources: S&P Global Market Intelligence and Alpha Vantage

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Alpha Vantage.

Last checked:

Aug 27, 2026

Data Sources Report a data error